Privia Raises 2026 Guidance After $374M MSSP Shared Savings
PRVA sits 34% above its 52-week low of $18.915.
Summary
Privia's ACOs delivered $374.0 million in 2025 MSSP shared savings, up 59.7%, and the company raised full-year 2026 guidance, including Adjusted EBITDA to $174-177 million from $154-157 million.
Key Events · Earnings and Guidance · PRVA
-
MSSP Shared Savings Jump 59.7%
For the 2025 Medicare Shared Savings Program performance year, Privia's ten ACOs generated $374.0 million in shared savings, a 59.7% increase from 2024; excluding the acquired Evolent Care Partners ACO, growth was 38.1%.
-
2026 Guidance Raised Across the Board
GAAP revenue guidance rises to $2,550-2,600 million from $2,500-2,550 million, Care Margin to $565-570 million from $535-540 million, and Adjusted EBITDA to $174-177 million from $154-157 million.
-
Adjusted EBITDA Growth of ~39.8%
At the midpoint, the updated 2026 guidance implies Adjusted EBITDA growth of approximately 39.8% compared with 2025, with EBITDA margin at the midpoint rising to 30.9% of Care Margin from 28.9%.
-
Cash Balance of at Least $550M Expected
Privia expects to end 2026 with at least $550 million in cash and cash equivalents, including the capital outlay for the American Choice Healthcare transaction and assuming the 2025 MSSP cash settlement occurs before year end.
Analysis · PRVA · Industrial Applications And Services
The headline number is $374.0 million in shared savings for the 2025 Medicare Shared Savings Program performance year, up 59.7% from 2024, generated across Privia's ten ACOs. Management used that result to lift full-year 2026 guidance across every line. Adjusted EBITDA guidance moves to $174-177 million from $154-157 million, roughly 39.8% growth at the midpoint versus 2025, and the company now expects to end the year with at least $550 million in cash even after paying for the American Choice Healthcare acquisition. Note that the MSSP savings themselves are shared with CMS and participating providers, so they are not pure company revenue; the guidance raise, however, is a direct management statement that the underlying economics are running ahead of the plan laid out on November 5.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRVA was trading at $25.26 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $18.92 to $28.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.